Delivery Order SPE2D021DA002-SPE2D324F274Q

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,602.92 and is for the delivery of the TWINRIX vaccine syringe to military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,602.92 and covers the delivery of Twinrix vaccine syringes to support the medical supply needs of the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $2,347.29 and a completion date of December 11, 2023. The contract is for the delivery of TWINRIX vaccine syringes, a pharmaceutical product used in military treatment facilities. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,546.48, is for the delivery of TWINRIX VACCINE SYRINGE, a specialized pharmaceutical product, by March 11, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,636.62, is for the delivery of 4,568,085,988 units of the TWINRIX vaccine syringe. The contract has a period of performance through May 1, 2025. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $95,392.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a completion date of June 14, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for $3,129.72 to provide the TWINRIX vaccine syringe. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products to support military treatment facilities worldwide. This delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of TWINRIX vaccine syringes, with a potential value of $1,399.26. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a complete line of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the Department of Defense. The...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F274Q
    Delivery Order

This firm fixed-price delivery order contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2D program. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes with a completion date of September 20, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a wide range of pharmaceutical products and medical supplies, including both routine and specialized medications, to support the medical needs of military personnel and their dependents across various Department of Defense healthcare facilities. This contract does not have a set-aside designation.

Generated 12/19/24, 9:15 AM